Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2543 (LINC02543) is a human long intergenic non-coding RNA (lincRNA), transcribed from a genomic region that does not overlap any known protein-coding genes. Its transcript is longer than 200 nucleotides, and like other lincRNAs, it is not translated into protein[3][5]. LincRNAs such as LINC02543 generally function via regulation of chromatin state, impacting gene transcription nearby or at a distance, and can influence cellular processes such as differentiation, cell cycle, and responses to stimuli. While many lincRNAs show highly specific patterns of expression and some have been implicated in disease mechanisms or as regulatory molecules, the precise function, clinical relevance, and disease associations of LINC02543 have not been characterized in detail based on currently available data[3][5]. There is no evidence that it is a therapeutically actionable target (e.g., receptor, enzyme, transporter), or that drugs or biomarkers are associated with it[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2543 (LINC02543).